US2002197608A1PendingUtilityA1

Detection of neoplasia by analysis of saliva

Assignee: UNIV JOHNS HOPKINS MEDPriority: Nov 12, 1993Filed: May 22, 2001Published: Dec 26, 2002
Est. expiryNov 12, 2013(expired)· nominal 20-yr term from priority
Inventors:David Sidransky
C07K 14/82C07K 14/4703C12Q 1/6827C12Q 1/6886A61B 10/0051C12Q 2600/156
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for detection of a cell proliferative disorder, such as cancer, are provided utilizing analysis of target mutant nucleic acids in saliva specimens are described. The presence of target mutant nucleic acids is indicative of a neoplastic disorder of the lung or the head and neck.

Claims

exact text as granted — not AI-modified
1 . A method for detecting cancer in a subject comprising: 
 isolating nucleic acid from a saliva specimen taken from the subject, and    assaying the nucleic acid for a genetic mutation associated with cancer,    wherein the presence of the mutation indicative of cancer in the subject.

Join the waitlist — get patent alerts

Track US2002197608A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.